Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary for 2.3.1.60 extracted from

  • Atasoy, A.R.; Ciftci, I.H.; Petek, M.
    Modifying enzymes related aminoglycoside: analyses of resistant Acinetobacter isolates (2015), Int. J. Clin. Exp. Med., 8, 2874-2880.
    View publication on PubMedView publication on EuropePMC
Search for more literature for 2.3.1.60

Cloned(Commentary)

Cloned (Comment) Organism
gene aacC1, genotyping Acinetobacter baumannii

Inhibitors

Inhibitors Comment Organism Structure
additional information determination of imipenem, meropenem, and gentamicin resistant clinical isolates Acinetobacter baumannii

Natural Substrates/ Products (Substrates)

Natural Substrates Organism Comment (Nat. Sub.) Natural Products Comment (Nat. Pro.) Rev. Reac.
additional information Acinetobacter baumannii determination of imipenem, meropenem, and gentamicin resistant clinical isolates ?
-
 ?

Organism

Organism UniProt Comment Textmining
Acinetobacter baumannii O05286 gene aacC1; diverse clinical isolates, gene aacC1
-

Source Tissue

Source Tissue Comment Organism Textmining
additional information analysis of enzyme expression in several clinical isolates, overview Acinetobacter baumannii
-

Substrates and Products (Substrate)

Substrates Comment Substrates Organism Products Comment (Products) Rev. Reac.
additional information determination of imipenem, meropenem, and gentamicin resistant clinical isolates Acinetobacter baumannii ?
-
 ?

Synonyms

Synonyms Comment Organism
3-N-aminoglycoside acetyltransferase
-
 Acinetobacter baumannii
aac(3)-Ia
-
 Acinetobacter baumannii

General Information

General Information Comment Organism
additional information presence of genes encoding the following aminoglycoside-modifying en­zymes: aph (3')-V1, aph (3')-Ia, aac (3)-Ia, aac (3) IIa, aac (6')-Ih, aac (6')-Ib and ant (2')-Ia responsible for resis­tance in 4 different groups of clinical isolates, overview Acinetobacter baumannii